Europe

This archive covers progress stories and milestones from across Europe, spanning health, climate policy, social equity, and scientific research. From small-nation experiments to E.U.-wide initiatives, these reports highlight what is working and why.

Micro X-ray of mushrooms with false colors, for article on psilocybin clinical trials

First European psychedelic drug trial clinic opens in the U.K.

Clerkenwell Health’s opening marks a turning point for psychedelic medicine, moving it from university labs into dedicated commercial infrastructure built to carry promising compounds through late-stage clinical trials. The clinic’s first focus is patients facing terminal diagnoses — a population where conventional treatments often fall short, and where earlier psilocybin studies showed lasting reductions in anxiety and depression after just one or two sessions. By serving multiple drug developers at once, the facility could meaningfully accelerate how quickly different psychedelic compounds reach the people who need them. It’s a signal that this field is ready to scale.

Depiction of microchip storing solar energy in liquid, for article on solar energy storage

‘Radical’ solar technology breakthrough allows energy to be stored for up to 18 years

Solar energy that lasts 18 years in a bottle? Researchers at Sweden’s Chalmers University have built a molecule that absorbs sunlight, holds it as a liquid, and releases it as electricity only when a catalyst says go. To prove it works, they charged the liquid with Swedish sun, shipped it to a partner lab in China, and three months later powered a tiny chip — just 800 nanometers thin — that turned the stored sunlight into electricity. Output is still small, but the concept is validated. If it scales, it points toward a future where clean energy isn’t tethered to grids or mining-heavy batteries, but travels quietly in a jar to wherever people need it.